Equinor and bp Bid for Third New York Offshore Wind Solicitation
Significant New Investments and Innovative Opportunities Envisioned for State NEW YORK–(BUSINESS WIRE)–Equinor and bp today…
Significant New Investments and Innovative Opportunities Envisioned for State NEW YORK–(BUSINESS WIRE)–Equinor and bp today…
NORTH BRUNSWICK, N.J., Jan. 26, 2023 (GLOBE NEWSWIRE) — BioAegis Therapeutics, Inc., a clinical-stage company…
Topical ketamine formulations could improve the methods of treating post-traumatic stress disorder (PTSD) MIAMI, Jan….
LONDON, Jan. 26, 2023 (GLOBE NEWSWIRE) — On Thursday, NordPass, the password management company, announced…
Pending sales posted their smallest year-over-year decline in three months as mortgage rates ticked down….
STAMFORD, Conn.–(BUSINESS WIRE)–Voyager Aviation Holdings, LLC (“VAH,” the “Company”) announced that the Company has recently…
The Fifth in Its Acquisition Spree of Security Technology Companies and Brands PASADENA, Calif.–(BUSINESS WIRE)–#acquisition–RealDefense…
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA releases a research report examining bank earnings during the past several years,…
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
Kurt Hediger’s arrival bolsters GCA’s industrial capital markets nationwide NEWPORT BEACH, Calif.–(BUSINESS WIRE)–Graystone Capital Advisors,…
NEWTON, Mass.–(BUSINESS WIRE)–Global technology media and purchase intent data and services company TechTarget, Inc. (Nasdaq:…
Leading Customer Data and Experience Platform (CDXP) company continues enhancing car buying and ownership journey…
TORONTO, Jan. 26, 2023 (GLOBE NEWSWIRE) — Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:…
LB101 is a conditionally tetravalent PD-L1xCD47 LockBody bispecific monoclonal antibody being developed for solid tumors BOSTON…
BOSTON, Jan. 26, 2023 (GLOBE NEWSWIRE) — LAPIX Therapeutics, Inc. (“LAPIX”), a biopharma company focused…
MINNEAPOLIS, Jan. 26, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), (“Panbela” or the…
CEO Gregory Gorgas to discuss developments related to the Company’s Cancer Appetite Recovery Study (CAReS) Presentation…
MIAMI, FL, Jan. 26, 2023 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a biopharmaceutical company…
BOTHELL, Wash., Jan. 26, 2023 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP) announces the…
SEATTLE, Jan. 26, 2023 (GLOBE NEWSWIRE) — Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a…